Merck in Late-Stage Talks to Acquire Prometheus Biosciences
Wall Street Journal
Merck & Co. is in late-stage talks to acquire Prometheus Biosciences Inc., according to people familiar with the matter, a move that could give the big drugmaker promising immune disease treatments.
https://www.wsj.com/articles/merck-in-late-stage-talks-to-acquire-prometheus-biosciences-eefe4909